Chemotherapy with PCV for low grade nonenhancing oligodendrogliomas and oligoastrocytomas

被引：0
|
作者：
Soffietti, R
Rudà, R
Borgognone, M
Schiffer, D
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A423 / A424
页数：2
相关论文
共 50 条
  • [31] PROLONGED RESPONSE WITHOUT PROLONGED CHEMOTHERAPY: A LESSON FROM PCV CHEMOTHERAPY IN LOW-GRADE GLIOMAS
    Peyre, Matthieu
    Cartalat-Carel, Stephanie
    Meyronet, David
    Sunyach, Marie-Pierre
    Jouanneau, Emmanuel
    Guyotat, Jacques
    Jouvet, Anne
    Frappaz, Didier
    Honnorat, Jerome
    Ducray, Francois
    NEURO-ONCOLOGY, 2010, 12 : 40 - 40
  • [32] CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas
    Felix Sahm
    Christian Koelsche
    Jochen Meyer
    Stefan Pusch
    Kerstin Lindenberg
    Wolf Mueller
    Christel Herold-Mende
    Andreas von Deimling
    Christian Hartmann
    Acta Neuropathologica, 2012, 123 : 853 - 860
  • [33] Procubain-lomustine-vincristine (PCV) chemotherapy and radiotherapy for low-grade gliomas
    Verret, B.
    Dumont, S.
    ONCOLOGIE, 2017, 19 (1-2) : 47 - 48
  • [34] DYNAMIC HISTORY OF LOW GRADE GLIOMAS TREATED WITH FIRST-LINE PCV CHEMOTHERAPY
    Peyre, M.
    Cartalat-Carel, S.
    Meyronet, D.
    Ricard, D.
    Jouvet, A.
    Pallud, J.
    Mokhtari, K.
    Guyotat, J.
    Jouanneau, E.
    Sunyach, M.
    Frappaz, D.
    Honnorat, J.
    Ducray, F.
    NEURO-ONCOLOGY, 2010, 12 : 16 - 17
  • [35] A mathematical model of diffuse low-grade gliomas treated with PCV chemotherapy.
    Ducray, F.
    Peyre, M.
    Ricard, D.
    Cajavec-Bernard, B.
    Grenier, E.
    Tod, M.
    Calvez, V.
    Frappaz, D.
    Sunyach, M.
    Vasiljevic, A.
    Pallud, J.
    Cartalat-Carel, S.
    Honnorat, J.
    Ribba, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Prolonged response without prolonged chemotherapy: A lesson from PCV chemotherapy in low-grade gliomas.
    Peyre, M.
    Cartalat-Carel, S.
    Meyronet, D.
    Sunyach, M.
    Jouanneau, E.
    Guyotat, J.
    Jouvet, A.
    Frappaz, D.
    Honnorat, J.
    Ducray, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951
    van den Bent, Martin J.
    Erdem-Eraslan, Lale
    Idbaih, Ahmed
    de Rooi, Johan
    Eilers, Paul H. C.
    Spliet, Wim G. M.
    den Dunnen, Wilfred F. A.
    Tijssen, Cees
    Wesseling, Pieter
    Smitt, Peter A. E. Sillevis
    Kros, Johan M.
    Gorlia, Thierry
    French, Pim J.
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5513 - 5522
  • [38] The changing management of low-grade astrocytomas and oligodendrogliomas
    Agulnik, Mark
    Mason, Warren P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 20 (06) : 1249 - +
  • [39] LOW-GRADE GLIOMAS, MIXED GLIOMAS, AND OLIGODENDROGLIOMAS
    MACDONALD, DR
    SEMINARS IN ONCOLOGY, 1994, 21 (02) : 236 - 248
  • [40] Computational design of improved standardized chemotherapy protocols for grade II oligodendrogliomas
    Perez-Garcia, Victor M.
    Ayala-Hernandez, Luis E.
    Belmonte-Beitia, Juan
    Schucht, Philippe
    Murek, Michael
    Raabe, Andreas
    Sepulveda, Juan
    PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (07)
12345